mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.05 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |